Epidemiological impact of SARS-CoV-2 vaccination: mathematical modeling analyses
M Makhoul, HH Ayoub, H Chemaitelly, S Seedat… - Vaccines, 2020 - mdpi.com
This study aims to inform SARS-CoV-2 vaccine development/licensure/decision-making/implementation,
using mathematical modeling, by determining key preferred vaccine product …
using mathematical modeling, by determining key preferred vaccine product …
[HTML][HTML] Mathematical modeling of the SARS-CoV-2 epidemic in Qatar and its impact on the national response to COVID-19
…, H Chemaitelly, S Seedat, M Makhoul… - Journal of Global …, 2021 - ncbi.nlm.nih.gov
Background Mathematical modeling constitutes an important tool for planning robust
responses to epidemics. This study was conducted to guide the Qatari national response to the …
responses to epidemics. This study was conducted to guide the Qatari national response to the …
SARS-CoV-2 infection hospitalization, severity, criticality, and fatality rates in Qatar
S Seedat, H Chemaitelly, HH Ayoub, M Makhoul… - Scientific reports, 2021 - nature.com
The SARS-CoV-2 pandemic resulted in considerable morbidity and mortality as well as
severe economic and societal disruptions. Despite scientific progress, true infection severity, …
severe economic and societal disruptions. Despite scientific progress, true infection severity, …
Age could be driving variable SARS-CoV-2 epidemic trajectories worldwide
…, H Chemaitelly, S Seedat, GR Mumtaz, M Makhoul… - PLoS …, 2020 - journals.plos.org
Current geographic spread of documented severe acute respiratory syndrome coronavirus
2 (SARS-CoV-2) infections shows heterogeneity. This study explores the role of age in …
2 (SARS-CoV-2) infections shows heterogeneity. This study explores the role of age in …
[HTML][HTML] Characterizing key attributes of COVID-19 transmission dynamics in China's original outbreak: model-based estimations
A novel coronavirus strain, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2),
emerged in China. This study aims to characterize key attributes of SARS-CoV-2 …
emerged in China. This study aims to characterize key attributes of SARS-CoV-2 …
[HTML][HTML] Estimates of global SARS-CoV-2 infection exposure, infection morbidity, and infection mortality rates in 2020
We aimed to estimate, albeit crudely and provisionally, national, regional, and global
proportions of respective populations that have been infected with SARS-CoV-2 in the first year …
proportions of respective populations that have been infected with SARS-CoV-2 in the first year …
Epidemiological impact of prioritising SARS-CoV-2 vaccination by antibody status: mathematical modelling analyses
HH Ayoub, H Chemaitelly, M Makhoul… - BMJ …, 2021 - innovations.bmj.com
Background Vaccines against SARS-CoV-2 have been developed, but their availability falls
far short of global needs. This study aimed to investigate the impact of prioritising available …
far short of global needs. This study aimed to investigate the impact of prioritising available …
Epidemiological differences in the impact of COVID-19 vaccination in the United States and China
M Makhoul, H Chemaitelly, HH Ayoub, S Seedat… - Vaccines, 2021 - mdpi.com
This study forecasts Coronavirus Disease 2019 (COVID-19) vaccination impact in two countries
at different epidemic phases, the United States (US) and China. We assessed the impact …
at different epidemic phases, the United States (US) and China. We assessed the impact …
Modeling the impact of COVID-19 vaccination in Lebanon: a call to speed-up vaccine roll out
…, M Jabbour, A Harb, LJ Abu-Raddad, M Makhoul - Vaccines, 2021 - mdpi.com
Four months into the SARS-CoV-2 vaccination campaign, only 10.7% of the Lebanese
population have received at least one dose, raising serious concerns over the speed of vaccine …
population have received at least one dose, raising serious concerns over the speed of vaccine …
[HTML][HTML] Modeling the population-level impact of treatment on COVID-19 disease and SARS-CoV-2 transmission
M Makhoul, F Abu-Hijleh, HH Ayoub, S Seedat… - Epidemics, 2022 - Elsevier
Different COVID-19 treatment candidates are under development, and some are becoming
available including two promising drugs from Merck and Pfizer. This study provides …
available including two promising drugs from Merck and Pfizer. This study provides …